Hairstetics Hair Implant Device Safety and Efficacy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02856308
Recruitment Status : Recruiting
First Posted : August 4, 2016
Last Update Posted : August 9, 2017
Information provided by (Responsible Party):

Brief Summary:

This is a prospective, single-arm, multi-center, international, open-label, non-randomized, clinical study.

The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair implant device in subjects affected with hair loss.

Condition or disease Intervention/treatment Phase
Alopecia Device: Hairstetics hair implant device Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Safety and Efficacy Evaluation of Hairstetics Hair Implant in Subjects Affected With Hair Loss - a Clinical Study
Study Start Date : March 2014
Estimated Primary Completion Date : March 2018
Estimated Study Completion Date : September 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Hairstetics hair implant device
Subjects will undergo the Hairstetics prosthetic hair implantation starting with a test of up to 100 fibers and up to 2 additional implantation sessions with up to 1500 fibers overall per subject. The implantation will be carried out according to the device IFU.
Device: Hairstetics hair implant device

Primary Outcome Measures :
  1. Acceptable number, duration and severity of expected adverse device/procedure effects [ Time Frame: 3 months following implantation ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Subject is ≥ 19 years old.
  2. Subject has hair loss and has chosen to undergo synthetic hair implantation.
  3. Subject has mental capacity to understand study guidelines and requirements (to maintain scalp hygiene, use of shampoo, delicate combing, etc.).
  4. Subject has been evaluated by the investigator to have a scalp condition in the planned area of implantation that is acceptable for entering the study and currently is NOT suffering from skin problems at planned implantation site or elsewhere that might affect the procedure and/or success as clinically evaluated by the investigator.
  5. Subject has Good general health.
  6. Woman of child bearing potential must have a negative pregnancy test.
  7. Subject willing to sign a written informed consent form (ICF) and the post implantation maintenance protocol.

Exclusion Criteria:

  1. Previous synthetic hair implantation or hair transplantation in the past 6 months.
  2. Currently suffering from skin problems at planned implantation site or elsewhere that might affect the procedure and/or success as clinically evaluated by the investigator.
  3. Currently receiving or have within the past 3 months received radiation- and/or chemotherapy.
  4. Currently using steroid product with Immunosuppressive treatment.
  5. Impaired coagulation.
  6. Serious illness that may affect subject compliance to protocol.
  7. Subject is using illegal drugs.
  8. Participating in other clinical study.
  9. Known allergy or hypersensitivity to Nitinol or Nickel or Titanium
  10. For woman: Pregnancy or breast feeding.
  11. Known allergy or intolerance for the prescribed antibiotics and in such a case, a different antibiotics for which the subject is not allergic or intolerance to, will be prescribed

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02856308

Contact: Igal Ruvinsky, PhD +972-72-2501630
Contact: Boaz Shenhav +972-72-2501630

Cabinet du Dr G. Beilin Recruiting
Paris, France
Contact: Ghislaine Beilin, MD         
Cabinet médical du Dr Jack Smadja Recruiting
Paris, France
Contact: Jack Smadja, MD         
Georges Mandel Office Surgery Clinic Recruiting
Paris, France
Contact: Marc Divaris, MD         
Paras hospital Recruiting
Gurgaon, India, 122002
Contact: Anil Ganjoo, MD         
Fortis Hospital Recruiting
New Delhi, India, 110088
Contact: Manjul Agrawal, MD         
Egoclinic Recruiting
Bucharest, Romania
Contact: Irinel Nedelcu, MD         
Metropolitan hospital Recruiting
Bucharest, Romania
Contact: Radu Jecan, MD         
United Kingdom
Revere clinic Recruiting
London, United Kingdom, W1G7JA
Contact: Sach Mohan, MD         
Sponsors and Collaborators

Responsible Party: Hairstetics Identifier: NCT02856308     History of Changes
Other Study ID Numbers: HET-03
First Posted: August 4, 2016    Key Record Dates
Last Update Posted: August 9, 2017
Last Verified: August 2017

Additional relevant MeSH terms:
Hair Diseases
Skin Diseases
Pathological Conditions, Anatomical